These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34118810)

  • 1. Practitioner assessment of mental health in dermatologic disease.
    Singh GK; Mostow EN
    Dermatol Online J; 2021 May; 27(5):. PubMed ID: 34118810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to recognize and approach psychiatric and psychosocial impairments in the pediatric dermatology patient with a primary dermatologic disease.
    Andrade G; Castelo-Soccio L
    Pediatr Dermatol; 2019 Sep; 36(5):759-763. PubMed ID: 31298424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of physician assistants in the delivery of dermatologic health care.
    Clark AR; Monroe JR; Feldman SR; Fleischer AB; Hauser DA; Hinds MA
    Dermatol Clin; 2000 Apr; 18(2):297-302. PubMed ID: 10791156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and immunosuppressants: An opinion pool of practicing dermatologists of India.
    Ray A; Debata I; Agrawal I; Panda M
    Dermatol Ther; 2020 Nov; 33(6):e14036. PubMed ID: 32697015
    [No Abstract]   [Full Text] [Related]  

  • 5. An online survey of the use of digital cameras by members of the British Association of Dermatologists.
    Hubbard VG; Goddard DJ; Walker SL
    Clin Exp Dermatol; 2009 Jun; 34(4):492-4. PubMed ID: 19175618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Dermatologic Care in Dutch Nursing Homes and Possible Improvements: A Nationwide Survey.
    Lubeek SF; van der Geer ER; van Gelder MM; Koopmans RT; van de Kerkhof PC; Gerritsen MJ
    J Am Med Dir Assoc; 2015 Aug; 16(8):714.e1-6. PubMed ID: 26059629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatopsychopharmacology.
    Brodin MB
    J Am Acad Dermatol; 2013 Aug; 69(2):316-7. PubMed ID: 23866870
    [No Abstract]   [Full Text] [Related]  

  • 8. Rate of body dysmorphic disorder in dermatology patients.
    Phillips KA; Dufresne RG; Wilkel CS; Vittorio CC
    J Am Acad Dermatol; 2000 Mar; 42(3):436-41. PubMed ID: 10688713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selected psychosomatic aspects of dermatologic practice].
    Stumpf A
    Hautarzt; 2012 Oct; 63(10):813-20; quiz 821-2. PubMed ID: 23052103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The knowledge, awareness, and practice patterns of dermatologists toward psychocutaneous disorders: results of a survey study.
    Jafferany M; Vander Stoep A; Dumitrescu A; Hornung RL
    Int J Dermatol; 2010 Jul; 49(7):784-9. PubMed ID: 20618498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and management of mental health issues by dermatologic surgeons: a survey of American Society for Dermatologic Surgery members.
    Sarwer DB; Spitzer JC; Sobanko JF; Beer KR
    Dermatol Surg; 2015 Mar; 41(3):352-7. PubMed ID: 25742557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case reports: suicidal ideation in the dermatology clinic.
    Brown CA; Lane JE; Davis LS
    J Drugs Dermatol; 2005; 4(4):495-8. PubMed ID: 16004025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety update on commonly used psychotropic medications in dermatology.
    Navi D; Koo J
    J Drugs Dermatol; 2006 Feb; 5(2):109-15. PubMed ID: 16485878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prior authorizations for dermatologic medications: An American Academy of Dermatology survey of US dermatology providers and staff.
    Secrest AM; Asgari MM; Kourosh AS; Barbieri JS; Albrecht J;
    J Am Acad Dermatol; 2017 Oct; 77(4):784-786. PubMed ID: 28917469
    [No Abstract]   [Full Text] [Related]  

  • 15. Skin cancer screening by dermatologists: prevalence and barriers.
    Federman DG; Kravetz JD; Kirsner RS
    J Am Acad Dermatol; 2002 May; 46(5):710-4. PubMed ID: 12004312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Detection of Emotional and Behavioral Disorders in Dermatology.
    García-Campayo J; Pérez-Yus MC; García-Bustinduy M; Daudén E
    Actas Dermosifiliogr; 2016 May; 107(4):294-300. PubMed ID: 26651326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of psychotropic drugs in dermatology: unique perspectives of a dermatologist and a psychiatrist.
    Park KK; Koo J
    Clin Dermatol; 2013; 31(1):92-100. PubMed ID: 23245980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychodermatology in Canada: A National Survey Assessment of Dermatologists' Perception, Practice Patterns, and Challenges.
    Turk T; Fujiwara E; Abba-Aji A; Mathura P; Dytoc M
    J Cutan Med Surg; 2021; 25(3):249-256. PubMed ID: 34039041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moisturizer prescription patterns among Australasian dermatologists.
    Shumack SP; Commens CA
    Australas J Dermatol; 1988; 29(3):151-3. PubMed ID: 3272123
    [No Abstract]   [Full Text] [Related]  

  • 20. A cross-sectional survey of knowledge, attitudes, and practice in the prescription of isotretinoin for transgender patients among academic dermatologists.
    Ensslin CJ; Khanijow K; Yenokyan G; Loss M
    J Am Acad Dermatol; 2019 Dec; 81(6):1426-1429. PubMed ID: 31648856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.